Cholera

Certainty Style Key
Hover over keys for definitions:
True   Likely   Speculative
Human Uniqueness Compared to "Great Apes": 
Likely Difference
Human Universality: 
Individual Universal (All Individuals Everywhere)
MOCA Domain: 
MOCA Topic Authors: 

Cholera is caused by the bacterium Vibrio cholerae, which secretes a toxin whose B subunit binds the cell surface ganglioside GM1, delivering a toxic A subunit to the interior of the intestinal cell, causing watery diarrhea. The famous bacteriologist Robert Koch found that he could not infect any other animals with the organism, and concluded that "...although these experiments were constantly repeated with material from fresh cholera cases, our mice remained healthy. We then made experiments on monkeys, cats, poultry, dogs and various other animals that we were able to get a hold of, but we never were able to arrive at anything in animals similar to the cholera". The reasons for this are unknown.  There are statements in the literature that chimpanzees are also resistant to cholera.

Cholera is a diarrheal disease caused by the Gram-negative bacteria Vibrio cholerae. The facultative pathogen causes serious illness and death in humans by secreting an AB5-subunit toxin. The B subunit binds gangliosides (sialated glycosphingolipids) on intestinal epithelium, causing endocytosis of the A subunit. Subsequent activation of adenylyl cyclase leads to excessive water and electrolyte secretion, dehydration, and death. (Nelson 2009, Baron 1996). The effects of the toxin persist until the intestinal cells turn over, meaning that secretory diarrhea usually persists even after the bacteria is killed with an appropriate antibiotic. Support therapy depends on oral rehydration therapy using a mixed glucose/saline solution. Disease control rests largely on good sanitation, and cholera contributed significantly to the development of epidemiology and the sanitation imperative. Descriptions of illness that are consistent with cholera go back 3,000 years to ancient Indian writers. The disease spread into China and southern Russia in 1817. Since then, there have been multiple pandemic level outbreaks, including the 1991 El Tor strain in Peru (Guerrant 2003, Freter 1995).  The lifecycle of the pathogen includes human and aquatic stages at is passes from infected human, contaminates nearby water, gets consumed, and then infects the intestinal wall of its next host.

Public Health Service physicians and Pakistani doctors examine cholera patient. Note the intravenous line for rehydration therapy. Photo by United States Information Service, 1964. Image courtesy of the National Library of Medicine
Cholera epidemic map of Nashville, Tennessee, 1873 by Ely McClellan. Similar to groundbreaking work by John Snow in London in 1854. Image courtesy of the National Library of Medicine
Map of Routes of Asiatic Cholera by Dr. John C. Peters, Published in Harper's Weekly, 1885 v. 29, p. 268. Image courtesy of the National Library of Medicine
Timing

Timing of appearance of the difference in the Hominin Lineage as a defined date or a lineage separation event. The point in time associated with lineage separation events may change in the future as the scientific community agrees upon better time estimates. Lineage separation events are defined in 2017 as:

  • the Last Common Ancestor (LCA) of humans and old world monkeys was 25,000 - 30,000 thousand (25 - 30 million) years ago
  • the Last Common Ancestor (LCA) of humans and chimpanzees was 6,000 - 8,000 thousand (6 - 8 million) years ago
  • the emergence of the genus Homo was 2,000 thousand (2 million) years ago
  • the Last Common Ancestor (LCA) of humans and neanderthals was 500 thousand years ago
  • the common ancestor of modern humans was 100 - 300 thousand years ago

Possible Appearance: 
6,000 thousand years ago
Probable Appearance: 
2,000 thousand years ago
Definite Appearance: 
100 thousand years ago
The Human Difference: 

Surprisingly, humans are the only natural host for the bacterium (Gyr 1979). Efforts to establish illness in animal models frustrated early researchers. Koch successfully infected guinea pigs by treating them with sodium bicarbonate to neutralize stomach acid and opium to paralyze the intestinal motility. Metchnikoff hypothesized that a newborn gut, unprotected by established flora, might be susceptible to vibrio, and successfully infected neonatal rabbits in 1894 (Ritchie 2009). Work by Taylor (1987) and Butterton (1996) also demonstrate that mice can be colonized with vibrio cholerae. Very few of the animal models recapitulate the secretory “rice-water” diarrhea classically observed in humans. In addition infection usually requires irritation or trauma to the intestinal lining, and health animals resist cholera infection. Great apes do not appear to suffer from cholera infection. Primate infection with Vibrio has been carried in lab using “monkey-adapted” Vibrio and protein deficient vervet monkeys (Gyr 1979). Natural Infection in wild primates has not been observed.

Mechanisms Responsible for the Difference: 

Work by Moustafa (2004) demonstrates that Vibrio cholerae neuraminidase, which cleaves sialic acids to promote toxin entry into the enterocyte, contains lectin domains that bind Neu5Ac, a sialic acid that is particularly enriched in humans. Great apes, like most mammals other than humans, also produce Neu5Gc, reducing the availability of Neu5Ac and possibly explaining pathogen specificity. The most recent debate about the disease surrounds horizontal gene transfer between pathogenic vibrio by an encoded bacteriophage carrying the CTX gene element. In combination with selection by wild bacteriophages, this horizontal transfer is thought to contribute to a rapidly evolving Vibrio cholerae genome.

Possible Selection Processes Responsible for the Difference: 

Human sialic acid differences may provide selective advantage or disadvantage depending on the context of the challenge. Particularly interesting is the arms race between human and pathogen molecular recognition. The elimination of the enzyme that synthesizes Neu5Gc may have decreased human susceptibility to a number of pathogens while providing new cell-surface patterns that human specific pathogens exploit.

Related MOCA Topics
Related Topics (hover over title for reason):

References

  1. Cholera transmission: the host, pathogen and bacteriophage dynamic., Nelson, Eric J., Harris Jason B., J Morris Glenn, Calderwood Stephen B., and Camilli Andrew , Nat Rev Microbiol, 2009 Oct, Volume 7, Issue 10, p.693-702, (2009)
  2. Vibrio cholerae interactions with the gastrointestinal tract: lessons from animal studies., Ritchie, Jennifer M., and Waldor Matthew K. , Curr Top Microbiol Immunol, 2009, Volume 337, p.37-59, (2009)
  3. Sialic acid recognition by Vibrio cholerae neuraminidase., Moustafa, Ibrahim, Connaris Helen, Taylor Margaret, Zaitsev Viateslav, Wilson Jennifer C., Kiefel Milton J., von Itzstein Mark, and Taylor Garry , J Biol Chem, 2004 Sep 24, Volume 279, Issue 39, p.40819-26, (2004)
  4. Cholera, diarrhea, and oral rehydration therapy: triumph and indictment., Guerrant, Richard L., Carneiro-Filho Benedito A., and Dillingham Rebecca A. , Clin Infect Dis, 2003 Aug 1, Volume 37, Issue 3, p.398-405, (2003)
  5. An ace up the sleeve of the cholera bacterium., Richardson, S H., and Wozniak D J. , Nat Med, 1996 Aug, Volume 2, Issue 8, p.853-5, (1996)
  6. Medical Microbiology, Baron, Samuel , (1996)
  7. The fatal enteric cholera infection in the guinea pig, achieved by inhibition of normal enteric flora., FRETER, R , J Infect Dis, 1955 Jul-Aug, Volume 97, Issue 1, p.57-65, (1955)
  8. Cholera studies: 1. History of the disease, Pollitzer, R , Bulletin of the World Health Organization, 1954, Volume 10, Issue 3, p.421 - 461, (1954)